Edition:
United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

3.50USD
21 Sep 2018
Change (% chg)

$-0.05 (-1.41%)
Prev Close
$3.55
Open
$3.50
Day's High
$3.50
Day's Low
$3.47
Volume
85,698
Avg. Vol
41,254
52-wk High
$11.05
52-wk Low
$2.80

Chart for

About

Immune Design Corp. is a clinical-stage immunotherapy company. The Company is focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. The Company has engineered its technologies to activate the immune system's natural ability to create tumor-specific cytotoxic T cells (CTLs) to... (more)

Overall

Beta: 1.75
Market Cap(Mil.): $168.58
Shares Outstanding(Mil.): 48.16
Dividend: --
Yield (%): --

Financials

  IMDZ.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -1.37 -- --
ROI: -55.14 1.50 12.72
ROE: -55.19 0.19 14.85

BRIEF-Immune Design Q1 Loss Per Share $0.28

* IMMUNE DESIGN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 02 2018

Earnings vs. Estimates